MedTrace Logo

Tbit System Precision and Correlation of Different Blood Samples

NCT04478812 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2024-04-05

No results posted yet for this study

Summary

The Tbit™ System will detect S100B and GFAP concentrations with the blood specimen to produce and compare repeated measures from 3 blood samples from 3 fingersticks from one subject and one 1 venous whole blood sample will be collected from the same subject, on 3 different Tbit™ System by 3 different operators.

Conditions

Interventions

DIAGNOSTIC_TEST

Single Group Assignment

Tbit™ System will detect S100B and GFAP concentrations with the blood specimen collected

Sponsors & Collaborators

  • BioDirection Inc

    lead INDUSTRY

Principal Investigators

  • Jerika Acosta, BSc · Medicept Inc.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-15
Primary Completion
2024-11-30
Completion
2024-11-30
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04478812 on ClinicalTrials.gov